Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice.
De Fazio
S R
SR
Bouve College of Pharmacy and Health Sciences, Northeastern University, Boston, Massachusetts 02115.
Plowey
J
J
Hartner
W C
WC
Gozzo
J J
JJ
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000276:immunology*; D004334:Drug Administration Schedule; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D011090:Polyenes / Q000627:therapeutic use*; D020123:Sirolimus; D012878:Skin Neoplasms / Q000276:immunology*; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus